Moreover, glutaminyl cyclase contributes to the pathogenesis of both Alzheimer’s disease and fatty liver disease and pyroglutamate formation of CCL2 has been suggested as a possible underlying mechanism in both diseases [111]. The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.